 |
市場調查報告書
商品編碼
1630571
全球臨床診斷的 6 大成長機會：2025 年Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025 |
||||||
新的測試核准和測試自動化解決方案推動轉型成長
診斷佔醫療總成本的2-3%，影響70%的臨床決策，是支持精準醫療各階段的無聲組成部分，包括風險分類、篩檢、早期診斷、預後、監測和復發一個冠軍。
發現和轉化基於血液的神經生物標記的獨特機會、尋求監管核准的藥物診斷組合的持續成長以及用於改進和完善治療決策的快速抗菌藥物耐藥性診斷我們需要診斷應用的內置適應性來改變醫療保健途徑。此外，鑑於該領域面臨的持續挑戰，包括病理學人才短缺、準確性問題、價格和資源分配不平等，雲端基礎的解決方案、遠端存取和即時資料監控正在經歷前所未有的演變，預計將重塑世界業務。
隨著該領域經歷了治療決策和精準路徑轉型的巨大轉變，技術進步、市場需求和患者期望的三位一體正在改變全球診斷生態系統。隨著公司尋求降低產品和服務價格、減少資本支出並獲得資金以改善網路安全，對更有效率診斷的需求不斷增加。相關人員的關鍵是透過儀表板和即時分析升級產品的資訊技術 (IT) 組件，從而推動對可提供精準治療的整合、可擴展資料庫診斷模型的需求。
目錄
2025 年的主要成長機會
- 策略要務
- 六大成長機會
- 成長機會 1：LIMS
- 成長機會2：NGS資訊學
- 成長機會3：智慧實驗室解決方案
- 成長機會 4：伴隨診斷
- 成長機會 5：神經血液測試
- 成長機會 6：快速抗菌藥物抗藥性診斷
- 下一步
- 免責聲明
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse.
The discovery and translation of blood-based neurology biomarkers, sustained growth in drug-diagnostic combinations seeking regulatory approval, and unique opportunities in rapid antimicrobial resistance diagnostics necessitate built-in adaptability in diagnostics applications to improve therapeutic decisions and transform precision healthcare pathways. Moreover, given the persistent challenges the sector is facing, including the pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources, cloud-based solutions, remote access, and real-time data monitoring are evolving unprecedentedly and promising to reshape operations globally.
As the sector undergoes a seismic shift to improve therapeutic decisions and transform precision pathways, the trifecta of technological advancements, market demands, and patient expectations is transforming the global diagnostics ecosystem. The need to make products and services more affordable, reduce capital expenditure, and free up funds to improve cybersecurity will forge demand for greater diagnostics efficiency. The key for stakeholders will be to upgrade products' information technology (IT) components through dashboards and real-time analytics and forge demand for a unified, scalable data-based diagnostic model capable of delivering precision care.
Table of Contents
Top Growth Opportunities for 2025
- Strategic Imperatives
- Top 6 Growth Opportunities
- Growth Opportunity 1: LIMS
- Growth Opportunity 2: NGS Informatics
- Growth Opportunity 3: Smart Lab Solutions
- Growth Opportunity 4: CDx
- Growth Opportunity 5: Neurology Blood Tests
- Growth Opportunity 6: Rapid Antimicrobial Resistance Diagnostics
- Next Steps
- Legal Disclaimer
